Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD
2011

Genetic Links Between COPD and Lung Cancer

Sample size: 1400 publication 10 minutes Evidence: moderate

Author Information

Author(s): Robert P. Young, Raewyn J. Hopkins, Chris F. Whittington, Bryan A. Hay, Michael J. Epton, Gregory D. Gamble

Primary Institution: Department of Medicine, Auckland Hospital, Auckland, New Zealand

Hypothesis

Are the genetic effects underlying COPD also important in susceptibility to lung cancer?

Conclusion

The study suggests that genetic susceptibility to lung cancer includes genes conferring susceptibility to COPD.

Supporting Evidence

  • Approximately 20-30% of chronic smokers develop COPD while 10-15% develop lung cancer.
  • 50-90% of lung cancer cases have pre-existing COPD.
  • The 15q25 locus confers susceptibility to lung cancer and COPD.
  • The 4q31 and 4q22 loci confer a reduced risk to both COPD and lung cancer.
  • The study suggests that genetic susceptibility to lung cancer includes genes conferring susceptibility to COPD.

Takeaway

Some people who get COPD might also be more likely to get lung cancer because of shared genes.

Methodology

The study involved a cross-sectional case-control design with subjects sub-phenotyped for COPD and matched for smoking exposure.

Potential Biases

Potential bias due to the use of healthy smokers as controls, which may not represent the general population.

Limitations

The study's sample sizes are small, particularly after sub-phenotyping the lung cancer cases for COPD.

Participant Demographics

Subjects were of Caucasian ancestry, aged 40 years or more, with a smoking history.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016476

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication